Treating asymptomatic bacteriuria before immunosuppressive therapy during multiple sclerosis: Should we do it?

Authors :: Rouzaud C
Hautecoeur P
Donze C
Heinzlef O
Dinh A
Creange A
Abdullatif A
Audouin B
Tourbah A
Berger E
Bourre B
Brochet B
Mekies C
Cabre P
Papeix C
Casez O
Brassat D
Defer G
Derache N
De Seze J
Dive D
LePage E
Fromont A
Gouider R
Edan G
Pelletier J
Grimaud J
Guennoc AM
Camdessanché JP
Kwiatkowski A
Laplaud D
Lebrun C
Debouverie M
Coustans M
Gout O
La Rochelle OA
Heinzlef O
Ouallet JC
Cavelou P
Hautecoeur P
Labauge P
Vermersch P
Wiertlewski S
Vukusic S
Marignier R
Schluep M
Seeldrayers P
Slassi I
Stankoff B
Thaite F
Moreau T
Thouvenot E
Zephir H
Ciron J
Collongues N
Kerschen P
Cohen M
Gueguen A
Mathey G
Carra C
Bernady P
Faucheux JM
Planque E
Donze C
Ruet A
Mouzawakh C
Pittion S
Source :: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2017 Nov; Vol. 18, pp. 161-163. Date of Electronic Publication: 2017 Aug 24.
Publication Year :: 2017

Subjects :: Anti-Bacterial Agents therapeutic use
Humans
Multicenter Studies as Topic
Multiple Sclerosis therapy
Bacteriuria therapy
Immunosuppressive Agents therapeutic use
Multiple Sclerosis complications

Full Text Access

Tools